Chemoinformaics analysis of p-coumaric acid-2
| Molecular Weight | 276.376 | nRot | 7 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 8 |
| Exact Molecular Weight | 276.173 | nRing | 1 |
| Solubility: LogS | -4.914 | nHRing | 0 |
| Solubility: LogP | 4.592 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 46.799 |
| nHD | 0 | BPOL | 28.417 |
| QED | 0.559 |
| Synth | 1.999 |
| Natural Product Likeliness | -0.034 |
| NR-PPAR-gamma | 0.137 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.938 |
| Pgp-sub | 0.01 |
| HIA | 0.006 |
| CACO-2 | -4.486 |
| MDCK | 0.0000205 |
| BBB | 0.202 |
| PPB | 0.984914 |
| VDSS | 0.675 |
| FU | 0.0286605 |
| CYP1A2-inh | 0.323 |
| CYP1A2-sub | 0.16 |
| CYP2c19-inh | 0.797 |
| CYP2c19-sub | 0.347 |
| CYP2c9-inh | 0.864 |
| CYP2c9-sub | 0.988 |
| CYP2d6-inh | 0.084 |
| CYP2d6-sub | 0.358 |
| CYP3a4-inh | 0.197 |
| CYP3a4-sub | 0.387 |
| CL | 8.344 |
| T12 | 0.237 |
| hERG | 0.034 |
| Ames | 0.057 |
| ROA | 0.026 |
| SkinSen | 0.939 |
| Carcinogencity | 0.751 |
| EI | 0.971 |
| Respiratory | 0.098 |
| NR-Aromatase | 0.087 |
| Antiviral | Yes |
| Prediction | 0.714096 |